(Q61915553)
Statements
An Open-label, Multiple Dose Study to Assess the Steady-state Skin Concentrations and Pharmacokinetics of Vildagliptin 50 mg BID for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes (English)
0 references
February 2008
0 references
December 2008
0 references
22
0 references
30 year
0 references
65 year
0 references